(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.31%) $0.935
(0.59%) $11.02
(0.18%) $0.801
(0.00%) $92.17
Live Chart Being Loaded With Signals
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China...
Stats | |
---|---|
Dagens volum | 8.06M |
Gjennomsnittsvolum | 9.40M |
Markedsverdi | 23.06B |
EPS | HKD0 ( 2024-03-25 ) |
Neste inntjeningsdato | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0.0870 ( 2023-06-01 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.63 |
ATR14 | HKD0.00600 (0.12%) |
Volum Korrelasjon
Shandong Weigao Group Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Shandong Weigao Group Korrelasjon - Valuta/Råvare
Shandong Weigao Group Økonomi
Annual | 2023 |
Omsetning: | HKD13.23B |
Bruttogevinst: | HKD6.61B (49.97 %) |
EPS: | HKD0.440 |
FY | 2023 |
Omsetning: | HKD13.23B |
Bruttogevinst: | HKD6.61B (49.97 %) |
EPS: | HKD0.440 |
FY | 2022 |
Omsetning: | HKD13.62B |
Bruttogevinst: | HKD7.11B (52.23 %) |
EPS: | HKD0.600 |
FY | 2021 |
Omsetning: | HKD13.15B |
Bruttogevinst: | HKD7.27B (55.27 %) |
EPS: | HKD0.500 |
Financial Reports:
No articles found.
Shandong Weigao Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0960 (N/A) |
HKD0 (N/A) |
HKD0.0870 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00175 | 2004-09-02 |
Last Dividend | HKD0.0870 | 2023-06-01 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | HKD1.546 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.44 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.51 | |
Div. Directional Score | 6.84 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3382.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
1587.HK | Ex Dividend Junior | 2023-05-23 | Annually | 0 | 0.00% | |
0631.HK | Ex Dividend Junior | 2023-06-05 | Sporadic | 0 | 0.00% | |
9919.HK | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
2169.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1171.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
0251.HK | Ex Dividend Junior | 2023-09-20 | Semi-Annually | 0 | 0.00% | |
3877.HK | Ex Dividend Junior | 2023-06-28 | Semi-Annually | 0 | 0.00% | |
1739.HK | No Dividend Player | 2023-09-05 | Sporadic | 0 | 0.00% | |
0778.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.151 | 1.500 | 6.97 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0595 | 1.200 | 8.02 | 9.62 | [0 - 0.3] |
returnOnEquityTTM | 0.0900 | 1.500 | -0.111 | -0.166 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.71 | 2.17 | [1 - 3] |
quickRatioTTM | 1.753 | 0.800 | 4.39 | 3.51 | [0.8 - 2.5] |
cashRatioTTM | 0.922 | 1.500 | 5.99 | 8.99 | [0.2 - 2] |
debtRatioTTM | 0.123 | -1.500 | 7.95 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 13.95 | 1.000 | 5.94 | 5.94 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.185 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.500 | 1.000 | 5.00 | 5.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.70 | 8.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.270 | 1.000 | 9.61 | 9.61 | [0.2 - 2] |
assetTurnoverTTM | 0.393 | 0.800 | -0.714 | -0.571 | [0.5 - 2] |
Total Score | 10.18 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.86 | 1.000 | 9.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0900 | 2.50 | -0.0713 | -0.166 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.54 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.163 | 1.500 | -2.25 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0844 | 1.000 | -0.389 | 0 | [0.1 - 0.5] |
Total Score | 3.51 |
Shandong Weigao Group
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.